nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—HTR2A—vein—ovarian cancer	0.00698	0.106	CbGeAlD
Ropinirole—DRD4—testis—ovarian cancer	0.00329	0.0499	CbGeAlD
Ropinirole—DRD5—female reproductive system—ovarian cancer	0.00269	0.0407	CbGeAlD
Ropinirole—HTR2B—myometrium—ovarian cancer	0.00257	0.0389	CbGeAlD
Ropinirole—DRD5—female gonad—ovarian cancer	0.00245	0.0371	CbGeAlD
Ropinirole—ADRA2C—myometrium—ovarian cancer	0.00202	0.0307	CbGeAlD
Ropinirole—HTR2B—uterine cervix—ovarian cancer	0.002	0.0303	CbGeAlD
Ropinirole—HTR2B—decidua—ovarian cancer	0.00191	0.0289	CbGeAlD
Ropinirole—HTR2B—endometrium—ovarian cancer	0.00181	0.0274	CbGeAlD
Ropinirole—HTR2B—uterus—ovarian cancer	0.00167	0.0253	CbGeAlD
Ropinirole—HTR1B—female reproductive system—ovarian cancer	0.00166	0.0252	CbGeAlD
Ropinirole—ADRA2A—myometrium—ovarian cancer	0.00161	0.0245	CbGeAlD
Ropinirole—HTR1D—female reproductive system—ovarian cancer	0.00161	0.0244	CbGeAlD
Ropinirole—HTR2C—female reproductive system—ovarian cancer	0.0016	0.0242	CbGeAlD
Ropinirole—ADRA2C—uterine cervix—ovarian cancer	0.00157	0.0239	CbGeAlD
Ropinirole—ADRA2C—decidua—ovarian cancer	0.0015	0.0227	CbGeAlD
Ropinirole—HTR2B—female reproductive system—ovarian cancer	0.0015	0.0227	CbGeAlD
Ropinirole—ADRA2C—endometrium—ovarian cancer	0.00142	0.0216	CbGeAlD
Ropinirole—HTR2B—vagina—ovarian cancer	0.00136	0.0205	CbGeAlD
Ropinirole—HTR2A—embryo—ovarian cancer	0.00132	0.02	CbGeAlD
Ropinirole—ADRA2C—uterus—ovarian cancer	0.00131	0.0199	CbGeAlD
Ropinirole—ADRA2A—uterine cervix—ovarian cancer	0.00126	0.019	CbGeAlD
Ropinirole—ADRA2A—decidua—ovarian cancer	0.0012	0.0181	CbGeAlD
Ropinirole—ADRA2A—endometrium—ovarian cancer	0.00114	0.0172	CbGeAlD
Ropinirole—HTR2A—epithelium—ovarian cancer	0.00108	0.0163	CbGeAlD
Ropinirole—ADRA2C—female gonad—ovarian cancer	0.00107	0.0163	CbGeAlD
Ropinirole—ADRA2C—vagina—ovarian cancer	0.00107	0.0162	CbGeAlD
Ropinirole—ADRA2A—gonad—ovarian cancer	0.00105	0.016	CbGeAlD
Ropinirole—ADRA2A—uterus—ovarian cancer	0.00105	0.0159	CbGeAlD
Ropinirole—DRD2—testis—ovarian cancer	0.000979	0.0148	CbGeAlD
Ropinirole—ADRA2C—testis—ovarian cancer	0.000952	0.0144	CbGeAlD
Ropinirole—ADRA2A—female reproductive system—ovarian cancer	0.000941	0.0143	CbGeAlD
Ropinirole—HTR2A—gonad—ovarian cancer	0.000896	0.0136	CbGeAlD
Ropinirole—HTR2B—lymph node—ovarian cancer	0.000877	0.0133	CbGeAlD
Ropinirole—ADRA2A—female gonad—ovarian cancer	0.000857	0.013	CbGeAlD
Ropinirole—ADRA2A—vagina—ovarian cancer	0.000851	0.0129	CbGeAlD
Ropinirole—HTR2A—female reproductive system—ovarian cancer	0.0008	0.0121	CbGeAlD
Ropinirole—ADRA2A—testis—ovarian cancer	0.00076	0.0115	CbGeAlD
Ropinirole—CYP3A4—female reproductive system—ovarian cancer	0.000741	0.0112	CbGeAlD
Ropinirole—CYP2D6—female reproductive system—ovarian cancer	0.000729	0.011	CbGeAlD
Ropinirole—HTR2A—vagina—ovarian cancer	0.000724	0.011	CbGeAlD
Ropinirole—ADRA2C—lymph node—ovarian cancer	0.00069	0.0105	CbGeAlD
Ropinirole—CYP2D6—female gonad—ovarian cancer	0.000663	0.0101	CbGeAlD
Ropinirole—HTR2A—testis—ovarian cancer	0.000646	0.00979	CbGeAlD
Ropinirole—CYP2D6—testis—ovarian cancer	0.000588	0.00892	CbGeAlD
Ropinirole—ADRA2A—lymph node—ovarian cancer	0.000551	0.00834	CbGeAlD
Ropinirole—Dry mouth—Docetaxel—ovarian cancer	0.000253	0.000278	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000253	0.000278	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000253	0.000278	CcSEcCtD
Ropinirole—Fatigue—Paclitaxel—ovarian cancer	0.000252	0.000277	CcSEcCtD
Ropinirole—Pollakiuria—Doxorubicin—ovarian cancer	0.000252	0.000276	CcSEcCtD
Ropinirole—Pain—Paclitaxel—ovarian cancer	0.00025	0.000275	CcSEcCtD
Ropinirole—Constipation—Paclitaxel—ovarian cancer	0.00025	0.000275	CcSEcCtD
Ropinirole—Haematuria—Epirubicin—ovarian cancer	0.00025	0.000275	CcSEcCtD
Ropinirole—Confusional state—Docetaxel—ovarian cancer	0.00025	0.000275	CcSEcCtD
Ropinirole—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000249	0.000273	CcSEcCtD
Ropinirole—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000248	0.000273	CcSEcCtD
Ropinirole—Oedema—Docetaxel—ovarian cancer	0.000248	0.000273	CcSEcCtD
Ropinirole—Weight increased—Doxorubicin—ovarian cancer	0.000248	0.000272	CcSEcCtD
Ropinirole—Epistaxis—Epirubicin—ovarian cancer	0.000248	0.000272	CcSEcCtD
Ropinirole—Infection—Docetaxel—ovarian cancer	0.000247	0.000271	CcSEcCtD
Ropinirole—Weight decreased—Doxorubicin—ovarian cancer	0.000246	0.000271	CcSEcCtD
Ropinirole—Sinusitis—Epirubicin—ovarian cancer	0.000246	0.000271	CcSEcCtD
Ropinirole—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000246	0.00027	CcSEcCtD
Ropinirole—Agranulocytosis—Epirubicin—ovarian cancer	0.000245	0.000269	CcSEcCtD
Ropinirole—Pneumonia—Doxorubicin—ovarian cancer	0.000244	0.000268	CcSEcCtD
Ropinirole—Shock—Docetaxel—ovarian cancer	0.000244	0.000268	CcSEcCtD
Ropinirole—Nervous system disorder—Docetaxel—ovarian cancer	0.000243	0.000267	CcSEcCtD
Ropinirole—Thrombocytopenia—Docetaxel—ovarian cancer	0.000243	0.000267	CcSEcCtD
Ropinirole—Infestation—Doxorubicin—ovarian cancer	0.000243	0.000267	CcSEcCtD
Ropinirole—Infestation NOS—Doxorubicin—ovarian cancer	0.000243	0.000267	CcSEcCtD
Ropinirole—Tachycardia—Docetaxel—ovarian cancer	0.000242	0.000266	CcSEcCtD
Ropinirole—Feeling abnormal—Paclitaxel—ovarian cancer	0.000241	0.000265	CcSEcCtD
Ropinirole—Skin disorder—Docetaxel—ovarian cancer	0.000241	0.000265	CcSEcCtD
Ropinirole—Bradycardia—Epirubicin—ovarian cancer	0.00024	0.000264	CcSEcCtD
Ropinirole—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000239	0.000263	CcSEcCtD
Ropinirole—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000238	0.000262	CcSEcCtD
Ropinirole—Haemoglobin—Epirubicin—ovarian cancer	0.000237	0.00026	CcSEcCtD
Ropinirole—Stomatitis—Doxorubicin—ovarian cancer	0.000237	0.00026	CcSEcCtD
Ropinirole—Anorexia—Docetaxel—ovarian cancer	0.000237	0.00026	CcSEcCtD
Ropinirole—Rhinitis—Epirubicin—ovarian cancer	0.000236	0.00026	CcSEcCtD
Ropinirole—Urinary tract infection—Doxorubicin—ovarian cancer	0.000236	0.000259	CcSEcCtD
Ropinirole—Conjunctivitis—Doxorubicin—ovarian cancer	0.000236	0.000259	CcSEcCtD
Ropinirole—Haemorrhage—Epirubicin—ovarian cancer	0.000236	0.000259	CcSEcCtD
Ropinirole—Hypoaesthesia—Epirubicin—ovarian cancer	0.000234	0.000258	CcSEcCtD
Ropinirole—Pharyngitis—Epirubicin—ovarian cancer	0.000234	0.000257	CcSEcCtD
Ropinirole—Urinary tract disorder—Epirubicin—ovarian cancer	0.000233	0.000256	CcSEcCtD
Ropinirole—Urticaria—Paclitaxel—ovarian cancer	0.000233	0.000256	CcSEcCtD
Ropinirole—Oedema peripheral—Epirubicin—ovarian cancer	0.000232	0.000255	CcSEcCtD
Ropinirole—Hypotension—Docetaxel—ovarian cancer	0.000232	0.000255	CcSEcCtD
Ropinirole—Haematuria—Doxorubicin—ovarian cancer	0.000232	0.000254	CcSEcCtD
Ropinirole—Connective tissue disorder—Epirubicin—ovarian cancer	0.000232	0.000254	CcSEcCtD
Ropinirole—Abdominal pain—Paclitaxel—ovarian cancer	0.000231	0.000254	CcSEcCtD
Ropinirole—Body temperature increased—Paclitaxel—ovarian cancer	0.000231	0.000254	CcSEcCtD
Ropinirole—Urethral disorder—Epirubicin—ovarian cancer	0.000231	0.000254	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00023	0.000252	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—ovarian cancer	0.000229	0.000252	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—ovarian cancer	0.000228	0.00025	CcSEcCtD
Ropinirole—Visual impairment—Epirubicin—ovarian cancer	0.000227	0.00025	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—ovarian cancer	0.000227	0.000249	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000226	0.000248	CcSEcCtD
Ropinirole—Insomnia—Docetaxel—ovarian cancer	0.000224	0.000247	CcSEcCtD
Ropinirole—Paraesthesia—Docetaxel—ovarian cancer	0.000223	0.000245	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—ovarian cancer	0.000222	0.000244	CcSEcCtD
Ropinirole—Dyspnoea—Docetaxel—ovarian cancer	0.000221	0.000243	CcSEcCtD
Ropinirole—Somnolence—Docetaxel—ovarian cancer	0.000221	0.000242	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—ovarian cancer	0.00022	0.000242	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—ovarian cancer	0.00022	0.000241	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—ovarian cancer	0.000219	0.000241	CcSEcCtD
Ropinirole—Flushing—Epirubicin—ovarian cancer	0.000219	0.00024	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—ovarian cancer	0.000219	0.00024	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—ovarian cancer	0.000219	0.00024	CcSEcCtD
Ropinirole—Dyspepsia—Docetaxel—ovarian cancer	0.000218	0.00024	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—ovarian cancer	0.000218	0.00024	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000217	0.000238	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—ovarian cancer	0.000216	0.000238	CcSEcCtD
Ropinirole—Decreased appetite—Docetaxel—ovarian cancer	0.000216	0.000237	CcSEcCtD
Ropinirole—Hypersensitivity—Paclitaxel—ovarian cancer	0.000216	0.000237	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000215	0.000237	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—ovarian cancer	0.000215	0.000236	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000214	0.000235	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000214	0.000235	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—ovarian cancer	0.000214	0.000235	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—ovarian cancer	0.000214	0.000235	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—ovarian cancer	0.000214	0.000235	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—ovarian cancer	0.000213	0.000234	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—ovarian cancer	0.000212	0.000233	CcSEcCtD
Ropinirole—Constipation—Docetaxel—ovarian cancer	0.000212	0.000233	CcSEcCtD
Ropinirole—Pain—Docetaxel—ovarian cancer	0.000212	0.000233	CcSEcCtD
Ropinirole—Chills—Epirubicin—ovarian cancer	0.000211	0.000232	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—ovarian cancer	0.00021	0.000231	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—ovarian cancer	0.00021	0.000231	CcSEcCtD
Ropinirole—Asthenia—Paclitaxel—ovarian cancer	0.00021	0.000231	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—ovarian cancer	0.000208	0.000229	CcSEcCtD
Ropinirole—Pruritus—Paclitaxel—ovarian cancer	0.000207	0.000228	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—ovarian cancer	0.000206	0.000227	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—ovarian cancer	0.000205	0.000225	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—ovarian cancer	0.000205	0.000225	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—ovarian cancer	0.000204	0.000224	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—ovarian cancer	0.000203	0.000223	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000203	0.000223	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—ovarian cancer	0.000202	0.000222	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—ovarian cancer	0.000202	0.000222	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—ovarian cancer	0.000202	0.000222	CcSEcCtD
Ropinirole—Tension—Epirubicin—ovarian cancer	0.000201	0.000221	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—ovarian cancer	0.000201	0.000221	CcSEcCtD
Ropinirole—Diarrhoea—Paclitaxel—ovarian cancer	0.0002	0.00022	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—ovarian cancer	0.000199	0.000219	CcSEcCtD
Ropinirole—Back pain—Epirubicin—ovarian cancer	0.000198	0.000218	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—ovarian cancer	0.000198	0.000217	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—ovarian cancer	0.000197	0.000217	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—ovarian cancer	0.000197	0.000216	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000196	0.000216	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—ovarian cancer	0.000196	0.000216	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—ovarian cancer	0.000196	0.000216	CcSEcCtD
Ropinirole—Chills—Doxorubicin—ovarian cancer	0.000196	0.000215	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—ovarian cancer	0.000195	0.000214	CcSEcCtD
Ropinirole—Dizziness—Paclitaxel—ovarian cancer	0.000194	0.000213	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—ovarian cancer	0.000193	0.000212	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—ovarian cancer	0.000193	0.000212	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—ovarian cancer	0.000191	0.00021	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—ovarian cancer	0.00019	0.000209	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—ovarian cancer	0.00019	0.000209	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—ovarian cancer	0.00019	0.000208	CcSEcCtD
Ropinirole—Agitation—Epirubicin—ovarian cancer	0.000188	0.000207	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—ovarian cancer	0.000187	0.000205	CcSEcCtD
Ropinirole—Tension—Doxorubicin—ovarian cancer	0.000186	0.000205	CcSEcCtD
Ropinirole—Vomiting—Paclitaxel—ovarian cancer	0.000186	0.000205	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—ovarian cancer	0.000186	0.000204	CcSEcCtD
Ropinirole—Malaise—Epirubicin—ovarian cancer	0.000185	0.000203	CcSEcCtD
Ropinirole—Rash—Paclitaxel—ovarian cancer	0.000185	0.000203	CcSEcCtD
Ropinirole—Dermatitis—Paclitaxel—ovarian cancer	0.000184	0.000203	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—ovarian cancer	0.000184	0.000203	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—ovarian cancer	0.000184	0.000202	CcSEcCtD
Ropinirole—Syncope—Epirubicin—ovarian cancer	0.000184	0.000202	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—ovarian cancer	0.000184	0.000202	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—ovarian cancer	0.000184	0.000202	CcSEcCtD
Ropinirole—Headache—Paclitaxel—ovarian cancer	0.000183	0.000202	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—ovarian cancer	0.000183	0.000201	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—ovarian cancer	0.000182	0.0002	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—ovarian cancer	0.000181	0.000199	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—ovarian cancer	0.00018	0.000198	CcSEcCtD
Ropinirole—Cough—Epirubicin—ovarian cancer	0.000179	0.000197	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—ovarian cancer	0.000179	0.000197	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—ovarian cancer	0.000178	0.000196	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—ovarian cancer	0.000178	0.000195	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—ovarian cancer	0.000177	0.000195	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000176	0.000193	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—ovarian cancer	0.000176	0.000193	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—ovarian cancer	0.000175	0.000193	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—ovarian cancer	0.000175	0.000192	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—ovarian cancer	0.000175	0.000192	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—ovarian cancer	0.000175	0.000192	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—ovarian cancer	0.000174	0.000192	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—ovarian cancer	0.000174	0.000191	CcSEcCtD
Ropinirole—Nausea—Paclitaxel—ovarian cancer	0.000174	0.000191	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000173	0.000191	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—ovarian cancer	0.000173	0.00019	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—ovarian cancer	0.000171	0.000188	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—ovarian cancer	0.000171	0.000188	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—ovarian cancer	0.000171	0.000187	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—ovarian cancer	0.00017	0.000187	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—ovarian cancer	0.00017	0.000187	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—ovarian cancer	0.00017	0.000187	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—ovarian cancer	0.000169	0.000185	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—ovarian cancer	0.000168	0.000184	CcSEcCtD
Ropinirole—Oedema—Epirubicin—ovarian cancer	0.000167	0.000184	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—ovarian cancer	0.000167	0.000183	CcSEcCtD
Ropinirole—Infection—Epirubicin—ovarian cancer	0.000166	0.000183	CcSEcCtD
Ropinirole—Cough—Doxorubicin—ovarian cancer	0.000166	0.000182	CcSEcCtD
Ropinirole—Shock—Epirubicin—ovarian cancer	0.000165	0.000181	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—ovarian cancer	0.000164	0.000181	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—ovarian cancer	0.000164	0.00018	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—ovarian cancer	0.000164	0.00018	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—ovarian cancer	0.000164	0.00018	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—ovarian cancer	0.000164	0.00018	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—ovarian cancer	0.000163	0.00018	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—ovarian cancer	0.000163	0.000179	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—ovarian cancer	0.000162	0.000178	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—ovarian cancer	0.000162	0.000178	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—ovarian cancer	0.000162	0.000178	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—ovarian cancer	0.000162	0.000178	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—ovarian cancer	0.000161	0.000177	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00016	0.000176	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—ovarian cancer	0.00016	0.000175	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—ovarian cancer	0.00016	0.000175	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—ovarian cancer	0.000158	0.000174	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—ovarian cancer	0.000158	0.000173	CcSEcCtD
Ropinirole—Rash—Docetaxel—ovarian cancer	0.000156	0.000172	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—ovarian cancer	0.000156	0.000172	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—ovarian cancer	0.000156	0.000172	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—ovarian cancer	0.000156	0.000172	CcSEcCtD
Ropinirole—Headache—Docetaxel—ovarian cancer	0.000155	0.000171	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—ovarian cancer	0.000155	0.00017	CcSEcCtD
Ropinirole—Infection—Doxorubicin—ovarian cancer	0.000154	0.000169	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000153	0.000168	CcSEcCtD
Ropinirole—Shock—Doxorubicin—ovarian cancer	0.000152	0.000167	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—ovarian cancer	0.000152	0.000167	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000152	0.000167	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—ovarian cancer	0.000151	0.000166	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—ovarian cancer	0.000151	0.000166	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—ovarian cancer	0.00015	0.000165	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—ovarian cancer	0.00015	0.000165	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00015	0.000165	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—ovarian cancer	0.000149	0.000164	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—ovarian cancer	0.000149	0.000164	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—ovarian cancer	0.000148	0.000162	CcSEcCtD
Ropinirole—Nausea—Docetaxel—ovarian cancer	0.000147	0.000162	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—ovarian cancer	0.000147	0.000162	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—ovarian cancer	0.000146	0.00016	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—ovarian cancer	0.000145	0.000159	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000145	0.000159	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—ovarian cancer	0.000144	0.000159	CcSEcCtD
Ropinirole—Pain—Epirubicin—ovarian cancer	0.000143	0.000157	CcSEcCtD
Ropinirole—Constipation—Epirubicin—ovarian cancer	0.000143	0.000157	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000141	0.000155	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—ovarian cancer	0.00014	0.000154	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—ovarian cancer	0.000139	0.000153	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—ovarian cancer	0.000138	0.000152	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—ovarian cancer	0.000138	0.000152	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—ovarian cancer	0.000138	0.000151	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000137	0.00015	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—ovarian cancer	0.000136	0.00015	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—ovarian cancer	0.000135	0.000148	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000134	0.000147	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—ovarian cancer	0.000134	0.000147	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—ovarian cancer	0.000133	0.000146	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—ovarian cancer	0.000132	0.000146	CcSEcCtD
Ropinirole—Pain—Doxorubicin—ovarian cancer	0.000132	0.000146	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—ovarian cancer	0.000132	0.000145	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—ovarian cancer	0.000132	0.000145	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—ovarian cancer	0.000128	0.00014	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000127	0.000139	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—ovarian cancer	0.000123	0.000136	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—ovarian cancer	0.000123	0.000135	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—ovarian cancer	0.000122	0.000135	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—ovarian cancer	0.000122	0.000135	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—ovarian cancer	0.00012	0.000132	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—ovarian cancer	0.000118	0.00013	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—ovarian cancer	0.000115	0.000126	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—ovarian cancer	0.000114	0.000125	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—ovarian cancer	0.000111	0.000122	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—ovarian cancer	0.000111	0.000122	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—ovarian cancer	0.00011	0.00012	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—ovarian cancer	0.000106	0.000117	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—ovarian cancer	0.000106	0.000116	CcSEcCtD
Ropinirole—Rash—Epirubicin—ovarian cancer	0.000106	0.000116	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—ovarian cancer	0.000105	0.000116	CcSEcCtD
Ropinirole—Headache—Epirubicin—ovarian cancer	0.000105	0.000115	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—ovarian cancer	0.000102	0.000113	CcSEcCtD
Ropinirole—Nausea—Epirubicin—ovarian cancer	9.94e-05	0.000109	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—ovarian cancer	9.85e-05	0.000108	CcSEcCtD
Ropinirole—Rash—Doxorubicin—ovarian cancer	9.77e-05	0.000107	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—ovarian cancer	9.76e-05	0.000107	CcSEcCtD
Ropinirole—Headache—Doxorubicin—ovarian cancer	9.7e-05	0.000107	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—ovarian cancer	9.2e-05	0.000101	CcSEcCtD
Ropinirole—DRD4—Signaling Pathways—MAPK1—ovarian cancer	4.03e-06	0.000168	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—ovarian cancer	4.03e-06	0.000168	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—ovarian cancer	4.03e-06	0.000168	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CD—ovarian cancer	4.01e-06	0.000167	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—ovarian cancer	4e-06	0.000167	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—ovarian cancer	3.99e-06	0.000167	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—ovarian cancer	3.99e-06	0.000167	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NRAS—ovarian cancer	3.98e-06	0.000166	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—ovarian cancer	3.98e-06	0.000166	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—ovarian cancer	3.98e-06	0.000166	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTEN—ovarian cancer	3.98e-06	0.000166	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.97e-06	0.000166	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.96e-06	0.000165	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—ovarian cancer	3.96e-06	0.000165	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—ovarian cancer	3.95e-06	0.000165	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—ovarian cancer	3.95e-06	0.000165	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—ovarian cancer	3.95e-06	0.000165	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—ovarian cancer	3.95e-06	0.000165	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—ovarian cancer	3.94e-06	0.000164	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CTNNB1—ovarian cancer	3.94e-06	0.000164	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—ovarian cancer	3.93e-06	0.000164	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NRAS—ovarian cancer	3.93e-06	0.000164	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—ovarian cancer	3.93e-06	0.000164	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—ovarian cancer	3.92e-06	0.000164	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CTNNB1—ovarian cancer	3.92e-06	0.000164	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.91e-06	0.000163	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	3.9e-06	0.000163	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MTOR—ovarian cancer	3.9e-06	0.000163	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAV1—ovarian cancer	3.9e-06	0.000163	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—ovarian cancer	3.89e-06	0.000162	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—ovarian cancer	3.88e-06	0.000162	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—ovarian cancer	3.87e-06	0.000162	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—ovarian cancer	3.87e-06	0.000162	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—ovarian cancer	3.86e-06	0.000161	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—ovarian cancer	3.85e-06	0.000161	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK1—ovarian cancer	3.85e-06	0.000161	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—ovarian cancer	3.85e-06	0.000161	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—ovarian cancer	3.84e-06	0.00016	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—ovarian cancer	3.84e-06	0.00016	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MTOR—ovarian cancer	3.84e-06	0.00016	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	3.84e-06	0.00016	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—ovarian cancer	3.82e-06	0.000159	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK3—ovarian cancer	3.81e-06	0.000159	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CTNNB1—ovarian cancer	3.81e-06	0.000159	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—ovarian cancer	3.81e-06	0.000159	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK3—ovarian cancer	3.76e-06	0.000157	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—ovarian cancer	3.75e-06	0.000156	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—ovarian cancer	3.75e-06	0.000156	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—ovarian cancer	3.74e-06	0.000156	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—ovarian cancer	3.73e-06	0.000156	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—ovarian cancer	3.72e-06	0.000155	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—ovarian cancer	3.71e-06	0.000155	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—ovarian cancer	3.71e-06	0.000155	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	3.69e-06	0.000154	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	3.66e-06	0.000153	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	3.66e-06	0.000153	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—ovarian cancer	3.66e-06	0.000153	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—ovarian cancer	3.63e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—ovarian cancer	3.63e-06	0.000152	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK1—ovarian cancer	3.63e-06	0.000152	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—ovarian cancer	3.63e-06	0.000152	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—ovarian cancer	3.62e-06	0.000151	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	3.62e-06	0.000151	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—ovarian cancer	3.61e-06	0.000151	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.6e-06	0.00015	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	3.6e-06	0.00015	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—ovarian cancer	3.59e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—ovarian cancer	3.59e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—ovarian cancer	3.58e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK1—ovarian cancer	3.58e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—ovarian cancer	3.58e-06	0.000149	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—ovarian cancer	3.56e-06	0.000149	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	3.56e-06	0.000149	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—ovarian cancer	3.56e-06	0.000148	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—ovarian cancer	3.56e-06	0.000148	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.55e-06	0.000148	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NRAS—ovarian cancer	3.55e-06	0.000148	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	3.54e-06	0.000148	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—ovarian cancer	3.53e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—ovarian cancer	3.52e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—ovarian cancer	3.51e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—ovarian cancer	3.51e-06	0.000146	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—ovarian cancer	3.5e-06	0.000146	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—ovarian cancer	3.49e-06	0.000146	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	3.49e-06	0.000146	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	3.49e-06	0.000146	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.47e-06	0.000145	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—ovarian cancer	3.47e-06	0.000145	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	3.46e-06	0.000144	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	3.45e-06	0.000144	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—ovarian cancer	3.44e-06	0.000144	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—ovarian cancer	3.44e-06	0.000143	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—ovarian cancer	3.43e-06	0.000143	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—ovarian cancer	3.43e-06	0.000143	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NRAS—ovarian cancer	3.42e-06	0.000143	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—ovarian cancer	3.42e-06	0.000143	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NRAS—ovarian cancer	3.41e-06	0.000142	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	3.4e-06	0.000142	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK3—ovarian cancer	3.4e-06	0.000142	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—ovarian cancer	3.39e-06	0.000142	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—ovarian cancer	3.38e-06	0.000141	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—ovarian cancer	3.38e-06	0.000141	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—ovarian cancer	3.37e-06	0.000141	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—ovarian cancer	3.36e-06	0.00014	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	3.36e-06	0.00014	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—ovarian cancer	3.36e-06	0.00014	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—ovarian cancer	3.34e-06	0.000139	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—ovarian cancer	3.34e-06	0.000139	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	3.33e-06	0.000139	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—ovarian cancer	3.32e-06	0.000139	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—ovarian cancer	3.32e-06	0.000138	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NRAS—ovarian cancer	3.31e-06	0.000138	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—ovarian cancer	3.3e-06	0.000138	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAV1—ovarian cancer	3.3e-06	0.000138	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—ovarian cancer	3.29e-06	0.000137	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—ovarian cancer	3.29e-06	0.000137	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	3.28e-06	0.000137	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	3.28e-06	0.000137	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	3.26e-06	0.000136	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	3.24e-06	0.000135	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—ovarian cancer	3.24e-06	0.000135	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	3.24e-06	0.000135	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK1—ovarian cancer	3.23e-06	0.000135	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—ovarian cancer	3.23e-06	0.000135	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—ovarian cancer	3.23e-06	0.000135	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.22e-06	0.000134	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—ovarian cancer	3.21e-06	0.000134	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	3.21e-06	0.000134	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—ovarian cancer	3.21e-06	0.000134	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	3.19e-06	0.000133	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—ovarian cancer	3.19e-06	0.000133	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	3.17e-06	0.000133	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—ovarian cancer	3.17e-06	0.000133	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—ovarian cancer	3.16e-06	0.000132	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.16e-06	0.000132	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	3.15e-06	0.000131	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—ovarian cancer	3.15e-06	0.000131	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—ovarian cancer	3.13e-06	0.000131	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	3.13e-06	0.000131	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.12e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	3.12e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—ovarian cancer	3.12e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	3.11e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	3.1e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—ovarian cancer	3.1e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—ovarian cancer	3.1e-06	0.000129	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	3.1e-06	0.000129	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—ovarian cancer	3.09e-06	0.000129	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—ovarian cancer	3.09e-06	0.000129	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—ovarian cancer	3.05e-06	0.000127	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—ovarian cancer	3.05e-06	0.000127	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—ovarian cancer	3.04e-06	0.000127	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	3.03e-06	0.000127	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	3.02e-06	0.000126	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	3.02e-06	0.000126	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	3.02e-06	0.000126	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—ovarian cancer	3.01e-06	0.000126	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.01e-06	0.000126	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NRAS—ovarian cancer	3.01e-06	0.000126	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—ovarian cancer	3.01e-06	0.000126	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	3e-06	0.000125	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—ovarian cancer	2.97e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—ovarian cancer	2.97e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NRAS—ovarian cancer	2.96e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—ovarian cancer	2.96e-06	0.000123	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—ovarian cancer	2.95e-06	0.000123	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	2.94e-06	0.000123	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—ovarian cancer	2.93e-06	0.000122	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—ovarian cancer	2.91e-06	0.000122	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—ovarian cancer	2.9e-06	0.000121	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK3—ovarian cancer	2.88e-06	0.00012	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—ovarian cancer	2.87e-06	0.00012	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—ovarian cancer	2.86e-06	0.000119	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	2.85e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	2.83e-06	0.000118	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—ovarian cancer	2.81e-06	0.000117	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—ovarian cancer	2.8e-06	0.000117	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—ovarian cancer	2.79e-06	0.000116	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—ovarian cancer	2.76e-06	0.000115	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—ovarian cancer	2.75e-06	0.000115	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK1—ovarian cancer	2.74e-06	0.000114	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—ovarian cancer	2.74e-06	0.000114	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—ovarian cancer	2.73e-06	0.000114	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	2.73e-06	0.000114	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.72e-06	0.000114	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—ovarian cancer	2.71e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	2.71e-06	0.000113	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	2.7e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	2.7e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—ovarian cancer	2.7e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	2.69e-06	0.000112	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	2.69e-06	0.000112	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.64e-06	0.00011	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	2.62e-06	0.000109	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—ovarian cancer	2.62e-06	0.000109	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—ovarian cancer	2.61e-06	0.000109	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—ovarian cancer	2.6e-06	0.000108	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—ovarian cancer	2.59e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	2.58e-06	0.000108	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—ovarian cancer	2.57e-06	0.000107	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—ovarian cancer	2.56e-06	0.000107	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAV1—ovarian cancer	2.55e-06	0.000106	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—ovarian cancer	2.55e-06	0.000106	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—ovarian cancer	2.55e-06	0.000106	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—ovarian cancer	2.54e-06	0.000106	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—ovarian cancer	2.54e-06	0.000106	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—ovarian cancer	2.51e-06	0.000105	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—ovarian cancer	2.51e-06	0.000105	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—ovarian cancer	2.49e-06	0.000104	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—ovarian cancer	2.48e-06	0.000104	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	2.45e-06	0.000102	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	2.45e-06	0.000102	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	2.42e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—ovarian cancer	2.4e-06	0.0001	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—ovarian cancer	2.39e-06	9.96e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	2.38e-06	9.93e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—ovarian cancer	2.35e-06	9.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	2.34e-06	9.77e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.32e-06	9.69e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—ovarian cancer	2.32e-06	9.69e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	2.32e-06	9.67e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.31e-06	9.62e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—ovarian cancer	2.3e-06	9.6e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—ovarian cancer	2.29e-06	9.57e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—ovarian cancer	2.26e-06	9.45e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—ovarian cancer	2.21e-06	9.24e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—ovarian cancer	2.2e-06	9.19e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—ovarian cancer	2.2e-06	9.18e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—ovarian cancer	2.16e-06	9.04e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	2.14e-06	8.94e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	2.13e-06	8.89e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—ovarian cancer	2.11e-06	8.79e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—ovarian cancer	2.08e-06	8.68e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—ovarian cancer	2.07e-06	8.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—ovarian cancer	2.06e-06	8.6e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.04e-06	8.52e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—ovarian cancer	1.99e-06	8.32e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	1.97e-06	8.22e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—ovarian cancer	1.94e-06	8.11e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—ovarian cancer	1.91e-06	7.98e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—ovarian cancer	1.88e-06	7.87e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.78e-06	7.43e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	1.74e-06	7.26e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.66e-06	6.93e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—ovarian cancer	1.54e-06	6.42e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.41e-06	5.87e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—ovarian cancer	1.36e-06	5.66e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—ovarian cancer	1.15e-06	4.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.08e-06	4.53e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—ovarian cancer	8.86e-07	3.7e-05	CbGpPWpGaD
